Latest News about ALNY
Recent news which mentions ALNY
Alnylam Pharmaceuticals, inc (ALNY) Q3 2021 Earnings Call Transcript
October 29, 2021
Tickers
ALNY
From Motley Fool
Why Alnylam Pharmaceuticals Stock Is Tanking This Week
October 29, 2021
Tickers
ALNY
From Motley Fool
66 Biggest Movers From Yesterday
October 29, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 28, 2021
From Benzinga
From Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
3 Top Breakout Stocks to Buy Right Now
October 15, 2021
From Motley Fool
3 Growth Stocks Near 52-Week Highs to Buy Anyway
October 14, 2021
From Motley Fool
Here's Why Inhibrx Stock Is on the Move Today
October 12, 2021
From Motley Fool
10 Health Care Stocks With Unusual Options Alerts In Today's Session
October 08, 2021
From Benzinga
This Robot-Run Large Cap ETF Has Less Apple, Microsoft, Amazon, Facebook Compared To SPY And Is Bullish On These Manufacturing Stocks Instead
August 18, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
From Benzinga
Analyzing Alnylam Pharmaceuticals's Unusual Options Activity
August 10, 2021
Tickers
ALNY
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
August 10, 2021
From Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
From Benzinga
Why Dicerna Pharmaceuticals Stock Is Tumbling on Friday
August 06, 2021
From Motley Fool
Why Is Dicerna Stock Getting Slammed Today?
August 06, 2021
From Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 06, 2021
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2021
August 04, 2021
From Benzinga
Tickers
ALNY
From Motley Fool
From Benzinga
Alnylam's Lumasiran Substantially Reduces Plasma Oxalate Levels PH1 Patients With Severe Renal Impairment
July 29, 2021
Tickers
ALNY
From Benzinga
You can beat stock market indexes — this fund manager has, and this is how she and her team did it
July 28, 2021
From MarketWatch
Why Is Novo Nordisk Buying a Rare-Disease Candidate?
July 24, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.